Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
ALS ( (AU:ALQ) ) has shared an announcement.
ALS Limited addressed a query from the ASX regarding the late lodgement of performance rights granted to Mr. Malcolm Deane. The company attributed the delay to human error within its Corporate Governance team and confirmed that necessary compliance procedures are in place. ALS has reviewed and enhanced its processes, embedding key regulatory obligations into new software and providing training to ensure future compliance. The company emphasizes its commitment to regulatory adherence and does not see the need for additional steps beyond enforcing existing protocols.
The most recent analyst rating on (AU:ALQ) stock is a Buy with a A$23.50 price target. To see the full list of analyst forecasts on ALS stock, see the AU:ALQ Stock Forecast page.
More about ALS
ALS Limited operates in the testing, inspection, and certification industry, providing analytical and laboratory services across various sectors including minerals, life sciences, energy, and industrials. The company focuses on delivering high-quality services to ensure compliance and safety standards for its clients worldwide.
Average Trading Volume: 1,343,723
Technical Sentiment Signal: Buy
Current Market Cap: A$11.1B
See more insights into ALQ stock on TipRanks’ Stock Analysis page.